Breaking News

Arranta Bio Expands Microbiome Capacity at CoE

Adds additional early-clinical GMP capacity for microbiome process development and early clinical supply at Gainesville, FL site.

By: Contract Pharma

Contract Pharma Staff

Arranta Bio, a microbiome contract development and manufacturing organization (CDMO), has completed its process development lab expansion project and a commitment to add additional early-clinical GMP capacity at its Center of Excellence for microbiome process development and early clinical supply. The purpose-built microbiome process development laboratories in a new dedicated building creates capacity for as many as 45 process development scientists at its Gainesville, FL site. As part of...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters